|Videos|February 27, 2023

Ascendia Pharmaceuticals - Sophisticated Formulations from Molecule to Formulation to Clinical

Key Learning Objectives

  • Ascendia is a specialty CDMO for biologicals and gene deliveries, as well as small molecules
  • Ascendia is expert in sophisticated formulations, and well as cGMP sterile and non-sterile clinical trial and commercial manufacturing
  • Ascendia is expanding its manufacturing capability to best serve customers and continue to be Partner of Choice for many of them

Related to this article

AAPS PharmSci 360 2026: Roller-Compacted Formulations
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.